Indication · Neurology & Neurosurgery
Dystonia
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
13
Cleared or approved since 2000
PMA and De Novo
13
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
28
115 device trials in all
Devices
0 devices via De Novo. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
No devices on this pathway.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
National Institute of Neurological Disorders and Stroke (NINDS)NIH
NCT01581580 · 200 participants (planned) · Start Aug 17, 2011 · Primary completion Dec 1, 2029
Device: Medtronic Activa Tremor Control System · For: Parkinson's Disease; Essential Tremor; Dystonia
Sites: Bethesda, Maryland
114 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on dystonia across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.